V-Wave

V Wave

Medical Devices, Canwood St, Caesarea, , 91301, California, 29219, United States, 51-200 Employees

vwavemedical.com

  • twitter
  • LinkedIn

phone no Phone Number: 18*********

Who is V-WAVE

V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with chronic Heart F...

Read More

map
  • 29219 Canwood St, Caesarea, California, 91301, United States Headquarters: 29219 Canwood St, Caesarea, California, 91301, United States
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • Neal Eigler CEO:   Neal Eigler

industries-icon Industry: Medical Devices

SIC SIC Code: 7389

checked-icon Does something look wrong? Fix it. | View contact records from V-WAVE

V-Wave Org Chart and Mapping

Neal Eigler

Chief Executive Officer

VP-Level
VP-Level
Employees

Bill Hughes

Chief Financial Officer

Marshall Adams

Regional Clinical Specialist / Field Clinical Engineer

Kelly Acosta

Director of Clinical Compliance

Carol Mosandl

Office Manager / Executive Assistant

Jessica Davis

Senior Executive Assistant / Chief Chaos Coordinator

Matt Borenzweig

Executive Vice President

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding V-Wave

Answer: V-Wave's headquarters are located at Canwood St, Caesarea, , 91301, California, 29219, United States

Answer: V-Wave's phone number is 18*********

Answer: V-Wave's official website is https://vwavemedical.com

Answer: V-Wave's revenue is $10 Million to $25 Million

Answer: V-Wave's SIC: 7389

Answer: V-Wave has 51-200 employees

Answer: V-Wave is in Medical Devices

Answer: V-Wave contact info: Phone number: 18********* Website: https://vwavemedical.com

Answer: V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with chronic Heart Failure (HF). As a leading cause of death and hospitalization, HF continues to affect millions of people worldwide. V-Waves vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life. The original concept and development started in Israel with a talented team of engineers and medical scientists. The companys senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access